Aneuploidy is a widespread abnormality with well-documented clinical complications. This chromosomal defect can be found in the cell lines you work on in your laboratories.
Traditional screening methods such as G-Banding or FISH can be helpful, but can turn out to be lengthy and costly for your organization.
On the other hand, digital PCR-based assays offer highly sensitive detection and fast turnaround time.
This led Stem Genomics to develop a specific aneuploidy detection solution for research scientists working on human cell lines.
The iCS-digital™ Aneuploidy test is composed of a set of 24 probes that target all 24 human chromosomes.
It allows the detection of whole chromosome gains and losses (trisomy, tetrasomy, monosomy, etc.).
Our digital PCR-based solution enables rapid and cost-effective screening for chromosomal abnormalities, delivering results in just 3 days from reception. It is ideal for routine monitoring of genomic stability.
This test is particularly useful to detect aneuploidy in adult stem cells, their differentiated derivatives and potentially any human cell type. However, for human embryonic and induced pluripotent stem cells, we recommend the iCS-digital™ PSC test and for hMSCs, the iCS-digital™ MSC test, specifically designed for these cell types.
Any human cell type
Cells in fresh culture media (or in cell culture supernatant)
Aneuploidy of any of the 24 chromosomes: whole chromosome gains & losses
>20% (depending on sample quality)
2-3 days after sample reception
Available as a service only
from one sample:
Join us LIVE for our webinar “Genomic stability made easy” to discover how Stem Genomics has turned cutting-edge technologies into easy testing solutions accessible to most labs.
Get expert opinions and user perspectives on our genomic stability assays in the context of iPSC research.
Happening on Tuesday, November 14, 6 pm CET
Please enter your e-mail address.